RIP
BMY icon

Reliant Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Reliant Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Hold
3,771
– – 0.19% 102
2025
Q4 		$203K Buy
+3,771
New +$181K 0.16% 105
2025
Q2 		– Sell
-3,771
Closed -$230K – 112
2025
Q1 		$230K Buy
3,771
+90
+2% +$5.25K 0.23% 85
2024
Q4 		$208K Buy
+3,681
New +$206K 0.18% 107

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Reliant Investment Partners's BMY Position: Q1 2026 in Review

Reliant Investment Partners held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 3,771 shares worth $229K. The position accounts for 0.19% of the portfolio, ranked #102.

Reliant Investment Partners first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $230K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Reliant Investment Partners held 3,771 shares of Bristol-Myers Squibb worth $229K as of Q1 2026.
  • Reliant Investment Partners left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.19% of Reliant Investment Partners's portfolio in Q1 2026, its #102 holding.
  • Reliant Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • Reliant Investment Partners's Bristol-Myers Squibb position peaked at $230K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Reliant Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.